CAROL DICKERSON: Open Payments
NPI 1568434173 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 24 payments from 16 companies in 2025. Trend: 2023 $812 · 2024 $1,381 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 3 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $88 |
| SHIELD THERAPEUTICS INC | 1 | $62 |
| Amgen Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Dexcom, Inc. | 1 | $29 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
Products named: TARPEYO, JARDIANCE, ACCRUFER, MOUNJARO, GVOKE HYPOPEN, Dexcom G6 Transmitter, TAVNEOS, ISTURISA.
Industry payments across KS — which companies pay providers there.
